Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
+9.13%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$100B
AUM Growth
-$15.7B
Cap. Flow
-$22.5B
Cap. Flow %
-22.43%
Top 10 Hldgs %
15.09%
Holding
3,879
New
490
Increased
1,156
Reduced
1,673
Closed
545

Sector Composition

1 Healthcare 22.93%
2 Technology 16.66%
3 Consumer Staples 12.21%
4 Consumer Discretionary 9.52%
5 Communication Services 9.49%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BKYI
2876
BIO-key International
BKYI
$5.18M
$422K ﹤0.01%
6,658
+5,375
+419% +$341K
IXN icon
2877
iShares Global Tech ETF
IXN
$5.91B
$422K ﹤0.01%
9,600
+1,200
+14% +$52.8K
VATE icon
2878
INNOVATE Corp
VATE
$65.3M
$421K ﹤0.01%
17,380
+2,170
+14% +$52.6K
TCON
2879
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$421K ﹤0.01%
4,075
-9,795
-71% -$1.01M
BW icon
2880
Babcock & Wilcox
BW
$250M
$419K ﹤0.01%
180,388
-62,500
-26% -$145K
NEPT
2881
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$419K ﹤0.01%
+142
New +$419K
IJJ icon
2882
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.19B
$418K ﹤0.01%
+6,200
New +$418K
FNDE icon
2883
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$7.65B
$417K ﹤0.01%
+17,600
New +$417K
RODM icon
2884
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.25B
$417K ﹤0.01%
+16,100
New +$417K
CVV icon
2885
CVD Equipment Corp
CVV
$21.1M
$413K ﹤0.01%
134,950
+5,658
+4% +$17.3K
INMB icon
2886
INmune Bio
INMB
$46.8M
$412K ﹤0.01%
+40,000
New +$412K
MYO icon
2887
Myomo
MYO
$33M
$411K ﹤0.01%
91,665
+62,643
+216% +$281K
CDZI icon
2888
Cadiz
CDZI
$295M
$410K ﹤0.01%
41,334
-106,100
-72% -$1.05M
VIGI icon
2889
Vanguard International Dividend Appreciation ETF
VIGI
$8.55B
$410K ﹤0.01%
+5,700
New +$410K
JDST icon
2890
Direxion Daily Junior Gold Miners Index Bear 2X Shares
JDST
$48.7M
$409K ﹤0.01%
+3,620
New +$409K
TOVX icon
2891
Theriva Biologics
TOVX
$3.95M
$408K ﹤0.01%
3,439
-119
-3% -$14.1K
CYAN
2892
DELISTED
Cyanotech Corp
CYAN
$408K ﹤0.01%
166,600
+9,800
+6% +$24K
DMAC icon
2893
DiaMedica Therapeutics
DMAC
$369M
$407K ﹤0.01%
96,000
-8,700
-8% -$36.9K
IJK icon
2894
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.31B
$407K ﹤0.01%
6,800
-2,400
-26% -$144K
STAB
2895
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$407K ﹤0.01%
206,751
-66,500
-24% -$131K
CIG icon
2896
CEMIG Preferred Shares
CIG
$5.81B
$405K ﹤0.01%
412,518
-2,943,476
-88% -$2.89M
HSDT icon
2897
Helius Medical Technologies
HSDT
$7.38M
$404K ﹤0.01%
1
MOGO
2898
Mogo
MOGO
$43.7M
$404K ﹤0.01%
93,306
+1,698
+2% +$7.35K
SNDL icon
2899
Sundial Growers
SNDL
$615M
$404K ﹤0.01%
+168,100
New +$404K
BRY icon
2900
Berry Corp
BRY
$251M
$400K ﹤0.01%
+126,040
New +$400K